ZebraSci’s experience in engineering, human factors, and commercialization for auto-injectors, needle safety devices and novel drug-device systems assists organizations in developing combination products from early concept through commercial launch and post-market monitoring.
Effective product development and commercialization is a central driver of business growth. Line extensions and evolutionary development are an important source of revenue and profit to businesses, but the greatest return often comes from revolutionary developments.
It is ZebraSci’s aim to show how all these requirements need to be translated into the development activities across the range of drug – device combination products, including prefilled syringes (PFS), auto-injectors, and needle safety devices.) We provide the expertise to integrate the drug and device aspects of combination product development for clients in the biopharma and pharma sectors.